Inex International Holdings

Inex Innovate is a Singapore-based molecular diagnostics company specializing in women's and fetal health. Formed by the merger of Inex Innovations Exchange and Nova-Genetic, the company focuses on developing and commercializing advanced diagnostic tests for early cancer detection and prenatal screening. Its flagship products include iGene, a non-invasive prenatal test (NIPT), and OvaCis, a rapid point-of-care diagnostic for identifying malignant ovarian cysts. The company leverages proprietary molecular technologies and next-generation sequencing to address unmet clinical needs in maternal-fetal medicine and oncology. Inex Innovate operates a CAP-accredited laboratory and maintains a strong commercial presence across Southeast Asia.